IP Library Granted Patent US 12,220,301
Granted Patent B2
US 12,220,301 · App. 16/960,940 · Granted Feb 11, 2025

Wound dressings and systems with therapeutic gas and negative pressure sources for incision management and related methods

Inventors: Justin Alexander Long (San Antonio, TX); Christopher Brian Locke (Bournemouth, GB); Kristine M. Kieswfetter (San Antonio, TX)
Assignee: Solventum Intellectual Properties Company
A61F13/05A61M1/73A61M1/74A61M1/90A61M1/94A61M1/962A61M1/964A61M1/85A61M2202/0208A61M2205/3324A61M2205/7536A61M2205/8206A61M2205/8243
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,220,301
App. No.
16/960,940
Granted
Feb 11, 2025
Kind
B2
Abstract

This disclosure includes wound dressings ( 18 ) and systems ( 10 ) with therapeutic gas and negative pressure sources for incision management. The dressing, which are configured to be coupled to tissue to facilitate delivery of oxygen to the tissue, comprise a manifold configured to permit communication of oxygen to the tissue the manifold ( 46 ) defining: a plurality of gas passageways ( 50 ); and a plurality of openings ( 62 ), one or more of which comprises a length ( 66 ) and a width ( 70 ) that is at least 50 percent less than the length; and a gas-occlusive layer ( 86 ) configured to be disposed over the manifold and coupled to the tissue such that an interior volume containing the manifold is defined between the gas-occlusive layer and the tissue and the gas-occlusive layer limits escape of oxygen from the interior volume.

Claims (19)

1. A dressing configured to be coupled to tissue to facilitate delivery of oxygen to the tissue, the dressing comprising:

a patient-interface layer configured to be in contact with the tissue, the patient-interface layer defining a plurality of openings configured to permit communication of oxygen and exudate through the patient-interface layer;

a first manifold configured to permit communication of oxygen to the tissue, the first manifold defining:

a plurality of gas passageways; and

a plurality of openings, one or more of which comprises a length and a width that is at least 50 percent less than the length;

a second manifold configured to permit communication of oxygen to the tissue, the second manifolding defining:

a plurality of gas passageways; and

a plurality of openings, one or more of which comprises a length and a width that is at least 50 percent less than the length;

a sorbent material configured to be disposed below the first manifold and above the second manifold and to capture exudate; and

a gas-occlusive layer configured to be disposed over the first manifold and the second manifold and coupled to the tissue such that an interior volume containing the first manifold and the second manifold is defined between the gas-occlusive layer and the tissue and the gas-occlusive layer limits escape of oxygen from the interior volume.

2. The dressing of claim 1 , comprising a port coupled to the gas-occlusive layer, wherein the port is configured to be releasably coupled to a port of a housing having a sidewall defining a chamber to permit communication of fluid between the chamber and the interior volume through the ports.

3. The dressing of claim 2 , comprising a filter configured to filter fluid that flows through the port, wherein the filter:

includes a layer of material that is bonded to an upper surface or a lower surface of the gas-occlusive layer; and

is configured to permit communication of oxygen into the interior volume through the port and restrict communication of exudate out of the interior volume through the port.

4. The dressing of claim 2 , comprising a valve coupled to the gas-occlusive layer and configured to relieve pressure within the interior volume when pressure within the interior volume exceeds a threshold pressure.

5. The dressing of claim 1 , comprising an oxygen source disposed within the interior volume, the oxygen source having an oxygen-generating material configured to release oxygen when exposed to a liquid.

6. The dressing of claim 5 , comprising a competitive agent disposed within the interior volume, the competitive agent configured to limit the communication of oxygen to the tissue.

7. The dressing of any of claim 5 , wherein the interior volume includes one or more capsules, each of which defines a pocket that includes a liquid.

8. The dressing of claim 1 , comprising a sensor configured to detect a presence of oxygen within the interior volume, wherein the sensor comprises a material configured to be disposed within the interior volume and to change color in response to a change in oxygen concentration within the interior volume.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066436/0225 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION LISTED ON SCHEDULE OF IP RIGHTS ATTACHED TO ASSIGNMENT AT LINES 55: 71; 89; 116-129; AND 131 NEED TO BE DELETED PREVIOUSLY RECORDED AT REEL: 064788 FRAME: 0823. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 13, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064886/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064788/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2023
From: LONG, JUSTIN ALEXANDER; KIESWETTER, KRISTINE M.; LOCKE, CHRISTOPHER BRIAN
To: KCI LICENSING, INC.
Reel/Frame 064684/0182 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2020
From: LONG, JUSTIN ALEXANDER; LOCKE, CHRISTOPHER BRIAN; KIESWETTER, KRISTINE M.
To: KCI LICENSING, INC.
Reel/Frame 053669/0246 →